Chemoinformaics analysis of (6,6-Dimethylbicyclo[3.1.1]hept-2-en-2-yl)methyl 2-methylbutanoate
| Molecular Weight | 236.355 | nRot | 4 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 9 |
| Exact Molecular Weight | 236.178 | nRing | 3 |
| Solubility: LogS | -5.137 | nHRing | 0 |
| Solubility: LogP | 4.454 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 42.657 |
| nHD | 0 | BPOL | 26.681 |
| QED | 0.551 |
| Synth | 4.357 |
| Natural Product Likeliness | 1.719 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.028 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.352 |
| MDCK | 0.0000215 |
| BBB | 0.956 |
| PPB | 0.696031 |
| VDSS | 1.218 |
| FU | 0.264726 |
| CYP1A2-inh | 0.52 |
| CYP1A2-sub | 0.213 |
| CYP2c19-inh | 0.442 |
| CYP2c19-sub | 0.797 |
| CYP2c9-inh | 0.46 |
| CYP2c9-sub | 0.407 |
| CYP2d6-inh | 0.027 |
| CYP2d6-sub | 0.388 |
| CYP3a4-inh | 0.306 |
| CYP3a4-sub | 0.32 |
| CL | 12.811 |
| T12 | 0.077 |
| hERG | 0.001 |
| Ames | 0.004 |
| ROA | 0.032 |
| SkinSen | 0.121 |
| Carcinogencity | 0.708 |
| EI | 0.912 |
| Respiratory | 0.941 |
| NR-Aromatase | 0.011 |
| Antiviral | Yes |
| Prediction | 0.880577 |